UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, DCD.C. 20549

FORM 8-K

~~Current~~CURRENT ~~Report Pursuant to Section 13 or 15(d)~~REPORT ~~Of the Securities Exchange Act of 1934~~

~~Date~~Pursuant ofto ~~Report~~Section 13 or 15(~~Date~~d) of ~~earliest~~the Securities ~~event~~Exchange ~~reported):~~Act ~~January 14,~~of ~~2005~~1934

Date of Report (Date of earliest event reported): April 21, 2005

CABG MEDICAL, INC.

(Exact name of registrant as specified in its charter)

Minnesota (State or Other Jurisdiction of Incorporation)


Minnesota	000-51050	41-958628

(State or other jurisdiction of incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)

14505 21st Avenue North, Suite 212
Minneapolis, MN 55447

(Address of principal executive offices) (Zip Code)

(763) 258-8005

(Registrant’s telephone number, including area code)

~~000-51050~~Check ~~(Commission~~the ~~File~~appropriate ~~Number)~~box 41below if the Form 8-~~958628~~K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (~~IRS~~see ~~Employer~~General ~~Identification~~Instruction NoA.2. below):

14505 — 21st Avenue North, Suite 212 Minneapolis, Minnesota 55447 (Address of Principal Executive Offices) (Zip Code)

(763) 258-8005 (Registrant’s telephone number, including area code)

Not Applicable (Former Name or Former Address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


o		Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


o		Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


o		Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


o		Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

TABLE OF CONTENTS

Item 8.01 Other Events. Item 9.01 Financial Statements and Exhibits. SIGNATURE EXHIBIT INDEX TO FORM 8-K Press Release


	Item 2.02. Results of Operations and Financial Condition.
	Item 9.01. Financial Statements and Exhibits.
SIGNATURES
EXHIBIT INDEX
Press Release

Item 82.0102. ~~Other~~Results ~~Events~~of Operations and Financial Condition.

On ~~January~~April 1421, 2005, CABG Medical, Inc. ~~announced~~(the ~~that~~“Company”) ~~the~~issued ~~over-allotment~~a ~~option~~press release to ~~purchase an~~report ~~additional~~final ~~825,000~~first ~~shares~~quarter ofresults ~~its~~for ~~common~~the ~~stock~~quarter atended aMarch 31, 2005. ~~price~~The offull ~~$5.50~~text ~~per~~press ~~share~~release ~~has~~is ~~been~~furnished ~~exercised~~as Exhibit 99.1 hereto and is incorporated by ~~the~~reference. ~~underwriters~~The ofinformation in this current report, including the ~~Company’s~~exhibit ~~recent~~hereto, ~~initial~~is ~~public~~not ~~offering.~~deemed ~~The~~“filed” ~~full~~for ~~text~~purposes of the ~~press~~Securities ~~release~~Exchange isAct ~~set~~of ~~forth~~1934, inas ~~Exhibit 99.1~~amended ~~attached~~(the ~~hereto~~“Exchange ~~and~~Act”), isor otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in ~~this~~any ~~Report~~filing under the Securities Act of 1933, as ifamended, ~~fully~~or the Exchange Act, except as expressly set forth ~~herein~~by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits.

(a) Financial ~~statements:~~Statements ~~None~~of Businesses Acquired.

~~(b)~~ Not ~~Pro forma financial information: None~~Applicable.

(cb) Pro ~~Exhibits:~~Forma Financial Information.

~~99.1~~ Not ~~Press release dated January 14, 2005~~Applicable.

2 (c) Exhibits.


Exhibit No.		Description
99.1		Press Release dated April 21, 2005

SIGNATURE Table of Contents

~~Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly~~SIGNATURES ~~caused this report to be signed on its behalf by the undersigned hereunto duly authorized.~~

~~Dated:~~ Pursuant ~~January 14~~to the requirements of the Securities Exchange Act of 1934, ~~2005~~the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

CABG MEDICAL, INC. By: /s/ John L. Babitt John L. Babitt President, Chief Operating Officer and Chief Financial Officer

~~3066126~~Dated: April 22, 2005

3 Table of Contents

~~Table~~EXHIBIT ~~of Contents~~INDEX

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549


Exhibit No.		Description
99.1		Press Release dated April 21, 2005

EXHIBIT INDEX TO FORM 8-K

Date of Report:		Commission File No.:
January 14, 2005		000-51050

CABG MEDICAL, INC.

EXHIBIT NO.				ITEM
	99.1			Press release dated January 14, 2005.

Filing Compare · CABG MEDICAL INC